"Why Applying Machine Learning to Biology is Hard – But Worth It: Bridging the Gap Between Tech and Bio"

"Why Applying Machine Learning to Biology is Hard – But Worth It: Bridging the Gap Between Tech and Bio"

In the world of technology and biology, the marriage of machine learning and biology is a complex and challenging endeavor. However, despite the difficulties, the potential benefits make it a venture worth pursuing. To successfully navigate this intersection, there are three types of people that need to be hired to build a balanced techbio company.

The first type of person is the biologist. Biologists have great imagination and intuition about mechanisms and complexity. They work with things that are invisible and often use illustrations to help visualize molecular processes. Their deep understanding of biology is crucial in adapting biological studies to the realm of machine learning.

The second type of person is the data scientist or machine learning expert. These individuals understand the intricacies of statistical learning and deep learning methods. They can take the deep information generated by biological studies and featurize it to make use of existing tools. However, they must be careful to optimize for machine learning, especially when dealing with a vast number of features compared to samples.

The third and most challenging type of person to find is the bridger – someone who has fluently worked in both the tech and bio fields. These individuals are essential in connecting the knowledge and problem spaces of both domains. They can effectively communicate and collaborate with biologists and data scientists, ensuring a cohesive and productive working environment.

When building a techbio company, it's crucial to avoid falling into certain traps. One common pitfall is underestimating the power of compound growth. Startups often resist manually recruiting users, as the absolute numbers may seem small at first. However, by focusing on individual customers and delighting them, compound growth can lead to exponential success.

Another trap to avoid is neglecting individual customers due to concerns about scalability. While scalability is important, founders should remember that delighting customers often scales better than expected. By creating a culture of customer-centricity, startups can find ways to make anything scale more effectively.

In the context of machine learning and biology, study design and the questions we ask must be adapted to the realm of big data and ML. The approach to biomolecular data may require adapting existing methods or building from scratch. The goal is to optimize the integration of data from multiple 'omics' technologies, such as genomics, transcriptomics, proteomics, or metabolomics, to study life in a concerted way.

To successfully navigate the challenges of applying machine learning to biology, here are three actionable pieces of advice:

1. Hire a diverse team: Build a balanced techbio company by hiring biologists, data scientists, and bridgers who can effectively communicate and collaborate.

2. Prioritize customer delight: Focus on individual customers and go above and beyond to create an exceptional user experience. Delighting customers will lead to compound growth and scalable success.

3. Optimize for machine learning: Carefully design studies, collect samples, run assays, and analyze data with machine learning in mind. Featurize deep information to take advantage of existing tools and overcome the big-p little-n problem.

In conclusion, the intersection of machine learning and biology presents significant challenges but holds immense potential. By hiring the right people, avoiding common traps, and adapting study design and analysis methods, techbio companies can bridge the gap between tech and bio successfully. The future of applying machine learning to biology is bright, with the ability to detect diseases before symptoms and make groundbreaking advancements in the field of life sciences.